Showing results (11-20 of 504) with videos related to
Sort By:
Pageof 51
Inflammatory Bowel Diseases|January 4, 2013
IL-4 Signaling Mechanisms in Inflammatory Bowel Disease Mononuclear PhagocytesY Rückert, U Schindler, T Heinig, et al.Hepato-Gastroenterology|February 1, 1990
Assessment of in vivo activated T cells in patients with Crohn's diseaseA Raedler, S Schreiber, A de Weerth, et al.Lancet (London, England)|November 18, 2000
Mechanisms in failure of infliximab for Crohn's diseaseS Nikolaus, A Raedler, T Kühbacker, et al.American Journal of Medical Genetics|May 19, 2000
Anticipation in inflammatory bowel disease: a phenomenon caused by an accumulation of confoundersJ Hampe, K Heymann, W Kruis, et al.Gut|February 1, 1992
Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel diseaseS Schreiber, A Raedler, A R Conn, et al.Gut|June 1, 1997
Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylateS Schreiber, J Hämling, E Zehnter, et al.Advances in Experimental Medicine and Biology|January 1, 1988
Activated Fc alpha T cells in Crohn's disease are involved in regulation of IgAA Raedler, S Schreiber, K H Schulz, et al.Gastroenterology|January 1, 1995
Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel diseaseS Schreiber, T Heinig, U Panzer, et al.Gastroenterology|October 1, 1991
Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel diseaseS Schreiber, R P MacDermott, A Raedler, et al.Lancet (London, England)|February 16, 1999
Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's diseaseS Schreiber, S Nikolaus, J Hampe, et al.Pageof 51